Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 9:27:18-23.
doi: 10.1016/j.jmsacl.2022.12.001. eCollection 2023 Jan.

Oxidized LDL is stable in human serum under extended thawed-state conditions ranging from -20 °C to room temperature

Affiliations

Oxidized LDL is stable in human serum under extended thawed-state conditions ranging from -20 °C to room temperature

Nilojan Jehanathan et al. J Mass Spectrom Adv Clin Lab. .

Abstract

Introduction: Oxidized LDL (oxLDL) is formed by the spontaneous reaction between aldehyde byproducts of lipid peroxidation and lysine residues of apolipoprotein B within LDL. Clinically, oxLDL is used as a marker of coronary artery disease and predictor of metabolic syndrome risk. Despite its popularity as a clinical marker, no systematic studies of oxLDL stability, in which serum or plasma has been pre-analytically exposed to an array of different time and temperature conditions, have been carried out.

Objective: To systematically evaluate the stability of oxLDL in human serum samples exposed to thawed conditions (> -30 °C) for varying periods of time while monitoring a second protein/small molecule redox system as a positive control for non-enzymatic biomolecular activity.

Methods: OxLDL was measured in serum samples, from 24 different humans, that had been pre-exposed to three different time courses at 23 °C, 4 °C and -20 °C using ELISA kits from Mercodia that employ the 4E6 mouse monoclonal antibody. A liquid chromatography/mass spectrometry-based marker of serum exposure to thawed conditions known as ΔS-Cys-Albumin was employed as a positive control.

Results: OxLDL was stable in serum exposed to 23 °C for up to 48 h, 4 °C for 21 days, or -20 °C for 65 days. ΔS-Cys-Albumin changed dramatically during these time courses (p < 0.001).

Conclusions: OxLDL is remarkably stable ex vivo in human serum samples exposed to thawed conditions.

Keywords: CAD, coronary artery disease; CHD, coronary heart disease; OxLDL, oxidized low-density lipoprotein; Oxidized LDL; Serum; Stability.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Stability of oxLDL in serum over time at thawed conditions of A) 23 °C, B) 4 °C, and C) −20 °C. Serum aliquots from 12 GI cancer patients and 12 cancer-free donors were monitored at each temperature. No significant differences were observed between any thawed-state exposure time point and a single set of control aliquots kept continuously at −80 °C.
Fig. 2
Fig. 2
ΔS-Cys-Albumin inversely reflects the oxidation of albumin to S-cysteinylated albumin . Here it serves as a positive control for ex vivo changes that occur in a different protein/small molecule redox system present in serum when it is exposed to thawed conditions at A) 23 °C, B) 4 °C, and C) −20 °C. Serum aliquots from the same 12 GI cancer patients and 12 cancer-free donors shown in Fig. 1 were monitored at each temperature. Data points represent the average of all 24 individuals and error bars represent inter-donor standard deviation.

Similar articles

Cited by

References

    1. Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 1994;8(15):1279–1284. - PubMed
    1. Holvoet P., Donck J., Landeloos M., Brouwers E., Luijtens K., Arnout J., Lesaffre E., Vanrenterghem Y., Collen D. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb. Haemost. 1996;76(5):663–669. - PubMed
    1. Holvoet P., Macy E., Landeloos M., Jones D., Jenny N.S., Van de Werf F., Tracy R.P. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin. Chem. 2006;52(4):760–764. - PubMed
    1. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., Sigal E., Sarkioja T., Witztum J.L., Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 1991;87(4):1146–1152. - PMC - PubMed
    1. Holvoet P., Perez G., Zhao Z., Brouwers E., Bernar H., Collen D. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J. Clin. Invest. 1995;95(6):2611–2619. - PMC - PubMed

LinkOut - more resources